EUVIMEDEUVIMED entdecken
Crossref

Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4

Miaomiao Feng iD, Haiwang Wu, Ling Zhu, Jie Gao, Gaopi Deng

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Miaomiao Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Phenanthrenes, Diterpenes. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Traditional Chinese Medicine of bureau of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) is a serious risk to women's health; it is necessary to explore less toxic and more effective therapies to cure CC. Triptolide (Tri) is the principal active constituent found in “Tripterygium Wilford,” has been shown to have antitumor effects. This study set up to demonstrate whether Tri is capable of inducing ferroptosis in CC cells and its potential mechanism. In vitro, Tri was used to treat CC cells, and lipid peroxidation levels in CC cells were detected by flow cytometry, immunofluorescence, and other experiments; the molecular mechanism of Tri treatment of CC was explored by western blot; moreover, the regulatory effects of Tri on the NRF2/GPX4/xCT axis were verified by overexpressing NRF2 in reverse. In vivo, CC cells tumor‐bearing mice were constructed to observe the effect of Tri treatment on tumor growth. In vitro, we have demonstrated that Tri prevents the growth and migration of CC cells. Further investigation revealed that Tri substantially enhances ferroptosis in CC cells by increasing lipid peroxidation accumulation. Mechanically, Tri significantly reduced the expression of NRF2, leading to a corresponding repression of the NRF2 downstream targets GPX4 and xCT. Moreover, overexpressing of NRF2 effectively reversed the impact of Tri on ferroptosis in CC cells. Additionally, animal experiments indicted that Tri markedly inhibited tumor size in nude mice by inhibiting the NRF2/GPX4/xCT axis. Tri exerts antitumor effects by triggering ferroptosis in CC cells through the NRF2/GPX4/xCT axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNF-E2-Related Factor 2PhenanthrenesDiterpenesPhospholipid Hydroperoxide Glutathione PeroxidaseUterine Cervical NeoplasmsFemaleAnimalsHumansEpoxy CompoundsMiceLipid PeroxidationCell Line, TumorMice, Inbred BALB CMice, NudeAmino Acid Transport System y+

Stichwörter der Autor:innen

NRF2/xCT/GPX4 axiscervical cancerferroptosistriptolide

Substanzen

triptolideNF-E2-Related Factor 2PhenanthrenesDiterpenesPhospholipid Hydroperoxide Glutathione PeroxidaseEpoxy CompoundsNFE2L2 protein, humanAmino Acid Transport System y+SLC7A11 protein, human

Autor:innen und Institutionen

  • Department of Gynaecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.

ORCID-Profile: Miaomiao Feng

Förderung

  • Traditional Chinese Medicine of bureau of Guangdong Province

Zitieren

APA

Feng, M., Wu, H., Zhu, L., Gao, J., & Deng, G. (2025). Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4. Phytotherapy Research. https://doi.org/10.1002/ptr.8398

Vancouver

Feng M, Wu H, Zhu L, Gao J, Deng G. Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4. Phytotherapy Research. 2025. doi:10.1002/ptr.8398

BibTeX
@article{Feng2025,
  author = {Feng, Miaomiao and Wu, Haiwang and Zhu, Ling and Gao, Jie and Deng, Gaopi},
  title = {Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8398}
}
Kostenlos starten →